Warning: The NCBI web site requires JavaScript to function. more...
Cellular responses to modified Plasmodium falciparum MSP119 antigens in individuals previously exposed to natural malaria infection.
Okafor CM, Anumudu CI, Omosun YO, Uthaipibull C, Ayede I, Awobode HO, Odaibo AB, Langhorne J, Holder AA, Nwuba RI, Troye-Blomberg M.
Malar J. 2009 Nov 23;8:263.
Related citations
An engineered Plasmodium falciparum C-terminal 19-kilodalton merozoite surface protein 1 vaccine candidate induces high levels of interferon-gamma production associated with cellular immune responses to specific peptide sequences in Gambian adults naturally exposed to malaria.
Bisseye C, Yindom LM, Simporé J, Morgan WD, Holder AA, Ismaili J.
Clin Exp Immunol. 2011 Dec;166(3):366-73. doi: 10.1111/j.1365-2249.2011.04467.x.
Malaria parasite-inhibitory antibody epitopes on Plasmodium falciparum merozoite surface protein-1(19) mapped by TROSY NMR.
Morgan WD, Lock MJ, Frenkiel TA, Grainger M, Holder AA.
Mol Biochem Parasitol. 2004 Nov;138(1):29-36.
Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1.
Johnson AH, Leke RG, Mendell NR, Shon D, Suh YJ, Bomba-Nkolo D, Tchinda V, Kouontchou S, Thuita LW, van der Wel AM, Thomas A, Stowers A, Saul A, Zhou A, Taylor DW, Quakyi IA.
Infect Immun. 2004 May;72(5):2762-71.
Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA.
Infect Immun. 2006 Aug;74(8):4573-80.
Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys.
Hui GS, Nikaido C, Hashiro C, Kaslow DC, Collins WE.
Infect Immun. 1996 May;64(5):1502-9.
Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies.
Guevara Patiño JA, Holder AA, McBride JS, Blackman MJ.
J Exp Med. 1997 Nov 17;186(10):1689-99.
The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
de Silva HD, Saleh S, Kovacevic S, Wang L, Black CG, Plebanski M, Coppel RL.
Malar J. 2011 Sep 16;10:266.
The human immune response to Plasmodium falciparum includes both antibodies that inhibit merozoite surface protein 1 secondary processing and blocking antibodies.
Nwuba RI, Sodeinde O, Anumudu CI, Omosun YO, Odaibo AB, Holder AA, Nwagwu M.
Infect Immun. 2002 Sep;70(9):5328-31.
Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, Gilson PR, Murphy VJ, Anders RF, Mueller I, Beeson JG.
Infect Immun. 2009 Mar;77(3):1165-74. Epub 2009 Jan 12.
Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum.
Egan AF, Chappel JA, Burghaus PA, Morris JS, McBride JS, Holder AA, Kaslow DC, Riley EM.
Infect Immun. 1995 Feb;63(2):456-66.
Antibody and cellular immune responses to Plasmodium falciparum histidine-rich protein II in malaria-exposed individuals in Orissa, India.
Das P, Grewal JS, Chauhan VS.
Trans R Soc Trop Med Hyg. 2010 May;104(5):371-3. Epub 2010 Jan 29.
Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19).
Ahlborg N, Ling IT, Holder AA, Riley EM.
Infect Immun. 2000 Apr;68(4):2102-9.
Shift in epitope dominance of IgM and IgG responses to Plasmodium falciparum MSP1 block 4.
Chang SP, Kayatani AK, Terrientes ZI, Herrera S, Leke RG, Taylor DW.
Malar J. 2010 Jan 13;9:14.
Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth.
Bruder JT, Stefaniak ME, Patterson NB, Chen P, Konovalova S, Limbach K, Campo JJ, Ettyreddy D, Li S, Dubovsky F, Richie TL, King CR, Long CA, Doolan DL.
Vaccine. 2010 Apr 19;28(18):3201-10. Epub 2010 Feb 25.
Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay.
Miura K, Zhou H, Diouf A, Moretz SE, Fay MP, Miller LH, Martin LB, Pierce MA, Ellis RD, Mullen GE, Long CA.
Clin Vaccine Immunol. 2009 Jul;16(7):963-8. Epub 2009 May 13.
Inhibitory antibodies specific for the 19-kilodalton fragment of merozoite surface protein 1 do not correlate with delayed appearance of infection with Plasmodium falciparum in semi-immune individuals in Vietnam.
Murhandarwati EE, Wang L, Black CG, Nhan DH, Richie TL, Coppel RL.
Infect Immun. 2009 Oct;77(10):4510-7. Epub 2009 Jul 20.
Plasmodium falciparum anti-MSP1-19 antibodies induced by MSP1-42 and MSP1-19 based vaccines differed in specificity and parasite growth inhibition in terms of recognition of conserved versus variant epitopes.
Hui G, Hashimoto C.
Vaccine. 2007 Jan 15;25(5):948-56. Epub 2006 Sep 18.
Antibodies elicited in adults by a primary Plasmodium falciparum blood-stage infection recognize different epitopes compared with immune individuals.
Eisen DP, Wang L, Jouin H, Murhandarwati EE, Black CG, Mercereau-Puijalon O, Coppel RL.
Malar J. 2007 Jul 2;6:86.
Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1.
Singh S, Kennedy MC, Long CA, Saul AJ, Miller LH, Stowers AW.
Infect Immun. 2003 Dec;71(12):6766-74.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on